Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)

被引:2
|
作者
Devpura, S. [1 ]
Siddiqui, M. S. [1 ]
Chen, D. [1 ]
Liu, D. [1 ]
Li, H. [1 ]
Kumar, S. [1 ]
Gordon, J. [1 ]
Ajlouni, M. [1 ]
Movsas, B. [1 ]
Chetty, I. J. [1 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
来源
XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013) | 2014年 / 489卷
关键词
MONTE-CARLO; RADIATION-THERAPY; PHOTON BEAMS; ALGORITHM; VMC;
D O I
10.1088/1742-6596/489/1/012007
中图分类号
O59 [应用物理学];
学科分类号
摘要
The purpose of this study was to systematically evaluate dose distributions computed with 5 different dose algorithms for patients with lung cancers treated using stereotactic ablative body radiotherapy (SABR). Treatment plans for 133 lung cancer patients, initially computed with a 1D-pencil beam (equivalent-path-length, EPL-1D) algorithm, were recalculated with 4 other algorithms commissioned for treatment planning, including 3-D pencil-beam (EPL-3D), anisotropic analytical algorithm (AAA), collapsed cone convolution superposition (CCC), and Monte Carlo (MC). The plan prescription dose was 48 Gy in 4 fractions normalized to the 95% isodose line. Tumors were classified according to location: peripheral tumors surrounded by lung (lung-island, N=39), peripheral tumors attached to the rib-cage or chest wall (lung-wall, N=44), and centrally-located tumors (lung-central, N=50). Relative to the EPL-1D algorithm, PTV D95 and mean dose values computed with the other 4 algorithms were lowest for "lung-island" tumors with smallest field sizes (3-5 cm). On the other hand, the smallest differences were noted for lung-central tumors treated with largest field widths (7-10 cm). Amongst all locations, dose distribution differences were most strongly correlated with tumor size for lung-island tumors. For most cases, convolution/superposition and MC algorithms were in good agreement. Mean lung dose (MLD) values computed with the EPL-1D algorithm were highly correlated with that of the other algorithms (correlation coefficient =0.99). The MLD values were found to be similar to 10% lower for small lung-island tumors with the model-based (conv/superposition and MC) vs. the correction-based (pencil-beam) algorithms with the model-based algorithms predicting greater low dose spread within the lungs. This study suggests that pencil beam algorithms should be avoided for lung SABR planning. For the most challenging cases, small tumors surrounded entirely by lung tissue (lung-island type), a Monte-Carlo-based algorithm may be warranted.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer
    Niazi, Tamim
    Elakshar, Sara
    Stroian, Gabriela
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) : 351 - 358
  • [22] Radiosensitivity of Colon and Rectal Lung Oligometastasis Treated With Stereotactic Ablative Radiotherapy
    Kinj, Remy
    Bondiau, Pierre-Yves
    Francois, Eric
    Gerard, Jean-Pierre
    Naghavi, Arash O.
    Leysalle, Axel
    Chamorey, Emmanuel
    Evesque, Ludovic
    Padovani, Bernard
    Ianessi, Antoine
    Benezery, Karen
    Doyen, Jerome
    CLINICAL COLORECTAL CANCER, 2017, 16 (03) : E211 - E220
  • [23] Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
    Yeo, Seung-Gu
    ONCOTARGETS AND THERAPY, 2017, 10 : 3285 - 3288
  • [24] Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR)
    Franzese, Ciro
    Vernier, Veronica
    Franceschini, Davide
    Comito, Tiziana
    Navarria, Pierina
    Clerici, Elena
    Teriaca, Maria Ausilia
    Massaro, Maria
    Di Cristina, Luciana
    Marini, Beatrice
    Galdieri, Carmela
    Mancosu, Pietro
    Tomatis, Stefano
    Scorsetti, Marta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10495 - 10503
  • [25] Difference in target dose distributions between Acuros XB and collapsed cone convolution/superposition and the impact of the tumor locations in clinical cases of stereotactic ablative body radiotherapy for lung cancer
    Inoue, Keiki
    Matsukawa, Hideaki
    Kasai, Yuki
    Edamitsu, Kana
    Matsumoto, Kazuki
    Suetsugu, Yoshiki
    Hirose, Taka-aki
    Fukunaga, Jun-ichi
    Shioyama, Yoshiyuki
    Sasaki, Tomonari
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1261 - 1266
  • [26] Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials
    Alayed, Yasir
    Cheung, Patrick
    Pang, Geordi
    Mamedov, Alexandre
    D'Alimonte, Laura
    Deabreu, Andrea
    Commisso, Kristina
    Commisso, Angela
    Zhang, Liang
    Quon, Harvey C.
    Musunuru, Hima Bindu
    Helou, Joelle
    Loblaw, D. Andrew
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (02) : 213 - 218
  • [27] Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer
    Hoffmeister-Wittmann, Paula
    Hoegen-Sassmannshausen, Philipp
    Wicklein, Livia
    Weykamp, Fabian
    Seidensaal, Katharina
    Springfeld, Christoph
    Dill, Michael T.
    Longerich, Thomas
    Schirmacher, Peter
    Mehrabi, Arianeb
    Mathy, Rene Michael
    Koehler, Bruno C.
    Debus, Juergen
    Herfarth, Klaus
    Liermann, Jakob
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [28] Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy?
    Senan, Suresh
    Paul, Marinus A.
    Lagerwaard, Frank J.
    LANCET ONCOLOGY, 2013, 14 (07) : E270 - E274
  • [29] Patient specific quality control for Stereotactic Ablative Body Radiotherapy (SABR): it takes more than one phantom
    Kron, T.
    Ungureanu, E.
    Antony, R.
    Hardcastle, N.
    Clements, N.
    Ukath, J.
    Fox, C.
    Lonski, P.
    Wanigaratne, D.
    Haworth, A.
    MICRO-MINI & NANO-DOSIMETRY & INNOVATIVE TECHNOLOGIES IN RADIATION THERAPY (MMND&ITRO2016), 2017, 777
  • [30] Clinical implementation of a PRIMO Monte Carlo-based dose verification and quality assurance model for stereotactic body radiotherapy (SBRT) treatment plans of the lung
    Sarin, B.
    Bindhu, B.
    Saju, B.
    Raghukumar, P.
    Nair, R. K.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2022, 20 (03): : 563 - 570